Innovations in Remnant Cholesterol Treatment

This chapter explores the critical role of remnant cholesterol in cardiovascular disease and diabetes management, discussing new drug options that effectively target this biomarker. It highlights recent clinical trial results, the integration of human genetics in drug development, and the challenges faced throughout the process. The conversation underscores the need for improved risk assessment tools to enhance patient outcomes in cardiovascular care.